Literature DB >> 22798347

Identification of molecular phenotypes and biased signaling induced by naturally occurring mutations of the human calcium-sensing receptor.

Katie Leach1, Adriel Wen, Anna E Davey, Patrick M Sexton, Arthur D Conigrave, Arthur Christopoulos.   

Abstract

More than 200 naturally occurring mutations have been identified in the human CaSR, which have been linked to diseases involving dysregulation of extracellular Ca(2+) homeostasis. These mutations have classically been termed "loss-" or "gain-of-function" mutations, which is an oversimplification given that amino acid changes can alter numerous molecular properties of a receptor. We thus sought to characterize the effects of 21 clinically relevant mutations, the majority located in the heptahelical domains and extracellular loop regions of the CaSR, using flow cytometry to measure cell surface receptor expression levels, and measurements of intracellular Ca(2+) mobilization and ERK1/2 phosphorylation to monitor receptor signaling. We identified distinct molecular phenotypes caused by these naturally occurring amino acid substitutions, which included combinations of loss- and gain-of-expression and changes in intrinsic signaling capacity. Importantly, we also identified biased signaling in the response of the CaSR to different mutations across the two pathways, indicating that some mutations resulted in receptor conformations that differentially altered receptor-coupling preferences. These findings have important implications for understanding the causes of diseases linked to the CaSR. A full appreciation of the molecular effects of these amino acid changes may enable the development of therapeutics that specifically target the molecular determinant of impairment in the receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798347     DOI: 10.1210/en.2012-1449

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

Review 1.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

Review 2.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

4.  Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.

Authors:  Caroline M Gorvin; Morten Frost; Tomas Malinauskas; Treena Cranston; Hannah Boon; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2018-11-01       Impact factor: 6.150

Review 5.  Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.

Authors:  P Jeffrey Conn; Craig W Lindsley; Jens Meiler; Colleen M Niswender
Journal:  Nat Rev Drug Discov       Date:  2014-09       Impact factor: 84.694

6.  Negative allosteric modulators of the human calcium-sensing receptor bind to overlapping and distinct sites within the 7-transmembrane domain.

Authors:  Tracy M Josephs; Andrew N Keller; Elham Khajehali; Aaron DeBono; Christopher J Langmead; Arthur D Conigrave; Ben Capuano; Irina Kufareva; Karen J Gregory; Katie Leach
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

7.  Towards a structural understanding of allosteric drugs at the human calcium-sensing receptor.

Authors:  Katie Leach; Karen J Gregory; Irina Kufareva; Elham Khajehali; Anna E Cook; Ruben Abagyan; Arthur D Conigrave; Patrick M Sexton; Arthur Christopoulos
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

8.  Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.

Authors:  A E Cook; S N Mistry; K J Gregory; S G B Furness; P M Sexton; P J Scammells; A D Conigrave; A Christopoulos; K Leach
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

9.  Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity.

Authors:  Natalie A Diepenhorst; Katie Leach; Andrew N Keller; Patricia Rueda; Anna E Cook; Tracie L Pierce; Cameron Nowell; Philippe Pastoureau; Massimo Sabatini; Roger J Summers; William N Charman; Patrick M Sexton; Arthur Christopoulos; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

10.  A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.

Authors:  Caroline M Gorvin; Valerie N Babinsky; Tomas Malinauskas; Peter H Nissen; Anders J Schou; Aylin C Hanyaloglu; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.